Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-speranza COVID-19 Project study protocol

S. MONNE, F. CORDERO, G. MUNOZ, J. ORTEGA, S. MARTOS, O. PUERTOLAS, A. SANGENIS, R. PEDROS, R. PEDROS and M. GONZALEZ
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022 May 1;

• Any: 01/05/2022
• FI: 3.1
• Article

NSAIDs, analgesics and antiplatelet drugs and kidney function decline: A case control study

S. MONNE, B. GONZALEZ, M. SAEZ, C. URGELL, J. SANTOS, J. DIEZ, O. PUERTOLAS, J. RUIZ and R. PEDROS
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022 May 1;

• Any: 01/05/2022
• FI: 3.1
• Article

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol (vol 23, 19, 2022)

F. MERA-CORDERO, S. BONET-MONNE, J. ALMEDA-ORTEGA, A. GARCIA-SANGENIS, O. CUNILLERA-PUERTOLAS, S. CONTRERAS-MARTOS, G. ALVAREZ-MUNOZ, R. MONFA, M. BALANZO-JOUE, R. MORROS and B. SALVADOR-GONZALEZ
Trials. 2022 Feb 9; . doi:10.1186/s13063-022-06073-7; PMID:35139906

• Any: 09/02/2022
• FI: 2.5
• Article

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

F. CORDERO, S. MONNE, J. ORTEGA, A. GARCIA-SANGENIS, O. PUERTOLAS, S. CONTRERAS-MARTOS, G. MUNOZ, R. ESCOLA, M. JOUE, R. PEDROS and B. SALVADOR-GONZALEZ
Trials. 2022 Jan 6; . doi:10.1186/s13063-021-05951-w; PMID:34991703

• Any: 06/01/2022
• FI: 2.5
• Article

Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain

E. DOPICO, F. RODRIGUEZ-FRIAS, I. UBILLOS, A. RANDO-SEGURA, D. GARCIA-CEHIC, J. GREGORI, Y. RANDO-MATOS, L. SOLSONA, J. NIUBO, J. ESTEBAN, J. COSTA, M. MARTINEZ and J. QUER
Infection and Drug Resistance. 2022 Jan 1; . doi:10.2147/IDR.S367715; PMID:36003985

• Any: 01/01/2022
• FI: 3.9
• Article